Skip to main content
. 2018 Jul 25;2018(7):CD012171. doi: 10.1002/14651858.CD012171.pub2

Jaffe 1978.

Methods Double‐blind, 2‐arm, parallel‐group, randomised controlled trial, with active comparator (no placebo) and 3 applications in total (no time period)
Participants Setting: 15 general practices, Bournemouth, UK
Sample size:
  • Number randomised: 106 participants, 106 ears

  • Number completed: 106 participants, 106 ears


Participant baseline characteristics:
  • Age: 9 to 89 years old

  • Gender: 46% female


Inclusion criteria: all patients presenting with wax in their ears for whom a cerumenolytic would normally be prescribed
Exclusion criteria: severe infection, tympanic membrane perforation
Interventions Intervention group (n = 53 participants; 53 ears): phenazone and sodium carbonate (Otocerol) 4 drops at night, 3 applications in total
Comparator group (n = 53 participants; 53 ears): arachis oil 57.3%, chlorobutanol 5%, para‐dichlorobenzene 2% (Cerumol) 5 drops at night, 3 applications in total
Use of additional interventions: syringing after drops treatment if required
Outcomes Primary outcome:
  • Degree of wax clearance


Secondary outcomes:
  • Adverse effects


Other outcomes reported by the study:
  • Requirement for syringing

  • Ease of syringing (where required)


Timing of measurements:
  • After 3 applications of ear drops (overnight), before syringing if required

  • After syringing if required

Funding sources No information provided
Declarations of interest No information provided
Notes Participants lost to follow‐up: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "Patients were randomly allocated according to a previously determined scheme"
Allocation concealment (selection bias) Unclear risk Comment: no information provided regarding concealment
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Comment: no information provided regarding blinding of participants
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Comment: no information provided regarding blinding of the outcome assessor
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Comment: the number randomised and withdrawn was not stated
Selective reporting (reporting bias) Unclear risk Comment: insufficient information; outcomes were not clearly defined in the methods
Other bias High risk Comment: overall high risk of bias for entire study, due to lack of information for all risk of bias domains